Your browser doesn't support javascript.
loading
Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma.
Suk, Fat-Moon; Liu, Chao-Lien; Hsu, Ming-Hua; Chuang, Yu-Ting; Wang, Jack P; Liao, Yi-Jen.
Afiliação
  • Suk FM; Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
  • Liu CL; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Hsu MH; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Chuang YT; Department of Chemistry, National Changhua University of Education, Changhua, Taiwan.
  • Wang JP; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Liao YJ; Department of International Medicine, Taipei City Hospital Ranai Branch, Taipei, Taiwan.
Sci Rep ; 9(1): 17259, 2019 11 21.
Article em En | MEDLINE | ID: mdl-31754201

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirrolidinas / Benzimidazóis / Resistencia a Medicamentos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirrolidinas / Benzimidazóis / Resistencia a Medicamentos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Taiwan